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Abstract
Background
Reflectance confocal microscopy (RCM) is an imaging device that permits non-invasive
visualization of cellular morphology and has been shown to improve diagnostic accuracy of
dermoscopically equivocal cutaneous lesions. The application of double reader concor-
dance evaluation of dermoscopy-RCM image sets in retrospective settings and its potential
application to telemedicine evaluation has not been tested in a large study population.
Objective
To improve diagnostic sensitivity of RCM image diagnosis using a double reader concor-
dance evaluation approach; to reduce mismanagement of equivocal cutaneous lesions in
retrospective consultation and telemedicine settings.
Methods
1000 combined dermoscopy-RCM image sets were evaluated in blind by 10 readers with
advanced training and internship in dermoscopy and RCM evaluation. We compared sensitiv-
ity and specificity of single reader evaluation versus double reader concordance evaluation as
well as the effect of diagnostic confidence on lesion management in a retrospective setting.
Results
Single reader evaluation resulted in an overall sensitivity of 95.2% and specificity of
76.3%, with misdiagnosis of 8 melanomas, 4 basal cell carcinomas and 2 squamous
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cell carcinomas. Combined double reader evaluation resulted in an overall sensitivity of
98.3% and specificity of 65.5%, with misdiagnosis of 1 in-situ melanoma and 2 basal cell
carcinomas.
Conclusion
Evaluation of dermoscopy-RCM image sets of cutaneous lesions by single reader evalua-
tion in retrospective settings is limited by sensitivity levels that may result in potential mis-
management of malignant lesions. Double reader blind concordance evaluation may
improve the sensitivity of diagnosis and management safety. The use of a second check
can be implemented in telemedicine settings where expert consultation and second opin-
ions may be required.
Introduction
Cutaneous tumor diagnosis can be difficult due to the diverse clinical and dermoscopic pre-
sentation of cutaneous lesions. In order to correctly identify an early melanoma (MM) the use
of dermoscopy has been shown to significantly increase the sensitivity and specificity of diag-
nosis when compared with traditional naked-eye examination [1,2]. In equivocal cases benign
lesions may be excised when further cytological information is required to rule out malig-
nancy. The efficacy of benign tumor differentiation from MM can be measured by the number
needed to excise ratio (NNE), for which dermoscopy ranges between 8.7 to 29.4, according to
the level of expertise and clinical setting [3,4].
In the past decade reflectance confocal microscopy (RCM) use in clinical practice has been
shown to further improve early MM diagnosis and help to reduce the number of unnecessary
excisions in different settings, as summarized in Table 1 [5–22] and confirmed by recent
reviews and meta-analysis [23,24].
Recently, the reliability of teleconsultation with dermoscopy images only [25,26] or com-
bined dermoscopy-RCM images [5,10,14] has been tested which showed the capability of an
accurate diagnosis but risk of mismanagement of potentially dangerous lesions, with diagnos-
tic accuracy depending greatly on the level of expertise. Since RCM is a newly adopted technol-
ogy its limitation to proper and safe diffusion may be due to the limited number of expert
users in the field and lack of dedicated training programs to properly support the necessary
knowledge acquisition and experience needed for safe and effective implementation in clinical
practice. With the potential for an increase in requests for distant expert consultation of RCM
images there is a need to provide proper, accurate and safe management of lesions sent for sec-
ond expert consultation and in addition provide an available and effective training program
for new users. Our goal in this study was to test the diagnostic sensitivity of readers who fol-
lowed a dedicated dermoscopy-RCM training program and evaluate the difference between
single reading versus double reading concordance evaluation of dermoscopy-RCM image sets.
Additionally, we intended to determine if it is possible to reduce mismanagement of equivocal
cutaneous lesions in retrospective consultation and telemedicine settings.
Materials and methods
Patient population
This was an Ethical Committee approved retrospective study (protocol 71.14; November 11,
2015) within the European Project DIAGNOPTICS (grant n. 621066) based on 1000
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Table 1. Previous studies evaluating the accuracy of reflectance confocal microscopy.
ref.
n.
First Author,
year
Journal Country Setting Total
lesion
number
Malignancies Sensitivity Specificity Study population Diagnostic
reference
5 Łudzik, 2016 PLoS One Poland, Italy Retrospective 316 12 MMs, 138
BCCs, 20
SCCs
94%
(Double
reading
98%)
54%
(Double
reading
42%)
Pink lesions Histopathology +
1 year follow-
up
6 Borsari,
2016
JAMA
Dermatol
Italy Prospective
Interventional
1279 246 MMs, 61
BCCs, 16
SCCs
97% 62% Dermoscopically
equivocal, any type
Histopathology +
1 year follow-
up
7 Guitera,
2016
Br J Dermatol Australia,
Italy
Retrospective 191 45 MMs, 48
BCCs, 10
SCCs
84% 47% Pink lesions Histopathology
8 Stanganelli,
2016
J Eu Acad
Dermatol
Venereol
Spain Retrospective 70 12 MMs 92% 46% Melanocytic lesions
changing at sequential
digital dermoscopy
Histopathology
9 Lovatto,
2016
Br J Dermatol Italy Retrospective 64 13 MMs 100% 69% Melanocytic lesions
changing at sequential
digital dermoscopy
Histopathology
10 Farnetani,
2015
JAMA
Dermatol
International Retrospective 100 20 MMs, 15
BCCs
89%
(Majority
100%)
79%
(Majority
80%)
Selected lesions
evaluated by 9
evaluators
Histopathology
11 Pellacani,
2015
Br J Dermatol Italy Prospective
Interventional
493 29 MMs, 39
BCCs
100% 47% Dermoscopically
equivocal lesions, any
type
Histopathology +
1 year follow-
up
12 Alarcon,
2015
Br J Dermatol Spain Prospective
Interventional
343 92 MMs 100% 31% Dermoscopically
equivocal melanocytic
lesions
Histopathology +
1 year follow-
up
13 Ferrari, 2014 J Eu Acad
Dermatol
Venereol
Italy Retrospective 322 70 MMs 96% 70% Dermoscopically
equivocal melanocytic
lesions
Histopathology
14 Rao, 2013 J American
Acad
Dermatol
USA, Italy Retrospective 334 9 MMs, 27
BCCs, 43
SCCs
98% 44% Dermoscopically
equivocal melanocytic
and non-melanocytic
lesions
Histopathology
15 Longo, 2013 Br J Dermatol Italy Retrospective 140 32 MMs, 34
NMSCs
96% 94% Dermoscopically
equivocal nodular
lesions
Histopathology
16 Guitera,
2012
J Invest
Dermatol
Italy,
Australia
Retrospective 710 216 MMs, 119
BCCs
88% 70% Clinically/
dermoscopically
equivocal melanocytic
and non-melanocytic
lesions
Histopathology
17 Guitera,
2010
J Invest
Dermatol
Italy, Spain,
Australia,
USA
Retrospective 219 81 LMs 85% 76% Facial lesions Histopathology
18 Guitera,
2009
J Invest
Dermatol
Italy,
Australia
Retrospective 326 123 MMs 91% 68% Dermoscopically
equivocal melanocytic
lesions
Histopathology
19 Segura,
2009
J American
Acad
Dermatol
Spain Retrospective 154 36 MMs, 27
BCCs
100% 57% Dermoscopically
equivocal melanocytic
and non- melanocytic
lesions
Histopathology
20 Langley,
2007
Dermatology Canada Prospective
Non-
Interventional
125 37 MMs 97% 83% Clinically equivocal
melanocytic lesion
Histopathology
21 Pellacani,
2007
J Invest
Dermatol
Italy Retrospective 351 136 MMs 92% 69% Dermoscopically
equivocal melanocytic
lesions
Histopathology
22 Pellacani,
2005
J American
Acad
Dermatol
Italy Retrospective 102 37 MMs 97% 72% Dermoscopically
equivocal melanocytic
lesions
Histopathology
MM–melanoma, BCC–basal cell carcinoma, SCC–squamous cell carcinoma
https://doi.org/10.1371/journal.pone.0187748.t001
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consecutive cases that were evaluated with dermoscopy and RCM imaging for diagnostic deci-
sion in order to rule out a diagnosis of MM during the period of January 2010 to August 2011
at the Dermatology Department at the University of Modena and Reggio Emilia (UNIMORE).
The inclusion criteria were: (i) lesion excised during the first visit or follow-up sequential digi-
tal dermoscopy (i.e. videodermoscopy; mole-mapping) control visit with corresponding histol-
ogy report; (ii) lesion not excised but with at least a 1 year stable digital dermoscopy and RCM
imaging follow-up with no significant structural changes in dermoscopy and absence of
increased atypia in RCM–considered to be benign and comparable to the histopathology gold
standard; (iii) availability of digital dermoscopy images; (iv) availability of a complete standard
set of RCM images. The first 1000 cases fitting the inclusion criteria were selected for this
study in order to obtain an even number of cases to be evaluated by the participating readers.
All patient cases were organized and renamed (0001–1000) by AW into separate folders with-
out the patient name, number or identifying information so that the participating readers were
blinded from the actual diagnosis and treatment course listed in the department database.
Reader training
Ten readers that included eight dermatology residents and two newly trained dermatology
specialists participated in a tutorial training program for a six month duration with a mini-
mum of 2000 dermoscopy-RCM case reviews and at least three months of clinical exposure to
bedside dermoscopy-RCM clinical decision making at the UNIMORE skin cancer unit.
Imaging protocol and evaluation
Dermoscopy images were obtained with a DermLite FOTO System (DermLite Photo; 3Gen, San
Juan Capistrano, CA, USA). RCM images were obtained with a reflectance confocal microscope
(Vivascope 1500; MAVIG GmbH, Munich, Germany). A minimum of three mosaics (VivaCube;
Caliber I.D., Inc., Rochester, NY, USA), images of 0.5 mm x 0.5 mm acquired and stitched into
composite images, were obtained at different depths, corresponding to the stratum granulosum/
spinosum, the dermal-epidermal junction (DEJ) and the papillary dermis [22]. The 1000 conse-
cutive cases selected for evaluation in this study included the following malignancies: MM, basal
cell carcinoma (BCC) and squamous cell carcinoma (SCC) and benign lesions (including naevi,
solar lentigos (SL), seborrheic keratosis (SK), lichen planus-like keratosis (LPLK) and actinic
keratosis (AK)), or other benign lesions that were not used during the training period of the 10
readers. The image sets were made available for evaluation during a time period of 3 months in
which each reader received a total of 200 randomized cases of dermoscopy-RCM image sets.
Cases were randomized so that each case was evaluated in blind by two different readers. None
of the readers obtained an identical case list and each case was only evaluated twice. Each reader
was asked to provide their management decision, degree of confidence and suspected diagnosis
based only on the provided image sets into a Microsoft excel file. Management recommendation
(hypothetical) was grouped into two categories: (i) excision or (ii) no-excision. Management
decision confidence level was graded: (i) low or (ii) high. In order to test concordance of double
reading, data from the excel files (Readers 1 to 10) were matched by computer and automatically
classified for management with excision when (1) management decision was concordant for
excision or when (2) management decision was discordant (i.e. one reader was recommending
excision and the other no-excision).
Statistical analysis
Statistical analyses were performed using IBM SPSS Statistics Professional software (release
20.0.0, 2011; SPSS Inc., Chicago, IL, U.S.A.). Mean and standard deviation were calculated for
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Breslow’s thickness. Diagnostic values of sensitivity and specificity of individual readers were
calculated for malignant versus benign lesions. Receiver Operating Characteristic (ROC) was
calculated using binary diagnosis values (0: all benign lesion types, 1: all malignant lesion
types) as the state variable and combination of “confidence” and “management” obtained by
the 2 readers, corresponding to the following scores: -3 high confidence for no-excision of
both readers; -2 no-excision suggested by both reader, one with high confidence and the other
with low confidence; -1 low confidence for no-excision of both readers; 0 disagreement (one
reader suggesting excision, while the other no-excision); +1 low confidence for excision of
both readers; +2 excision suggested by both reader, one with high confidence and the other
with low confidence; +3 high confidence for excision of both readers.
Results
Based on histologic diagnosis there were 176 malignant cases that included MM (83 cases,
mean Breslow’s thickness: 0.537 mm; standard deviation: 0.693 mm), BCC (87 cases) and SCC
(6 cases). The remaining 824 cases included 749 naevi, of which 16 were spitz naevi, SL/SK/
LPLK/AK (58 cases) and other benign lesions that included dermatofibromas, angiokerato-
mas, angiomas and other benign lesions classified as other (17 cases). The evaluation of 200
cases by each of the ten confocal readers was compared with the actual diagnosis resulting in
2000 total evaluations (each case evaluated by 2 different readers). Overall reader diagnostic
performance is reported in (Table 2) (S1 Table).
Table 2. Individual management performance of single reader evaluations.
Reader
number
Overall
Sensitivity
Overall
Specificity
MM
sensitivity
BCC
sensitivity
SCC
sensitivity
Naevi
(no spitz)
specificity
Spitz naevi
specificity
SK/SK/
LPLK/AK/
Other
specificity
R1 23/25 (92.0%) 139/175
(79.4%)
13/14
(92.9%)
10/11
(90.9%)
N/A 130/163
(79.8%)
0/2
(0%)
7/8
(87.5%)
R2 31/33
(93.9%)
125/167
(74.9%)
15/17
(88.2%)
16/16
(100%)
N/A 112/146
(76.7%)
0/4
(0%)
13/16
(81.3%)
R3 35/35
(100%)
132/165
(80.0%)
15/15
(100%)
18/18
(100%)
2/2
(100%)
120/147
(81.6%)
0/3
(0%)
9/10
(90.0%)
R4 41/42
(97.6%)
132/158
(83.5%)
14/14
(100%)
24/25
(96%)
3/3
(100%)
116/138
(84.1%)
0/2
(0%)
9/10
(90.0%)
R5 40/40
(100%)
118/160
(73.8%)
22/22
(100%)
17/17
(100%)
1/1
(100%)
104/140
(74.3%)
0/5
(0%)
12/13
(92.3%)
R6 34/37
(91.9%)
128/163
(78.5%)
13/15
(86.7%)
20/21
(95.2%)
1/1
(100%)
113/143
(79.0%)
0/2
(0%)
12/15
(80.0%)
R7 31/31
(100%)
114/169
(67.5%)
17/17
(100%)
13/13
(100%)
1/1
(100%)
109/157
(69.4%)
0/2
(0%)
4/8
(50.0%)
R8 36/37
(97.3%)
109/163
(66.9%)
20/20
(100%)
15/16
(93.8%)
1/1
(100%)
99/144
(68.8%)
0/5
(0%)
7/10
(70.0%)
R9 36/42
(85.7%)
131/158
(82.9%)
19/21
(90.5%)
17/19
(89.5%)
0/2
(0%)
115/135
(85.2%)
2/5
(40.0%)
11/15
(73.3%)
R10 28/30
(93.3%)
129/170
(75.9%)
9/11
(81.8%)
18/18
(100%)
1/1
(100%)
116/153
(75.8%)
0/2
(0%)
9/11
(81.8%)
Single
Overall
335/352
(95.2%)
1257/1648
(76.3%)
157/166
(94.6%)
168/174
(96.5%)
10/12 (83.3%) 1134/1466
(77.4%)
2/32 (6.2%) 121/150
(80.6%)
Double
Overall
173/176
(98.3%)
540/824
(65.5%)
82/83 (98.8%) 85/87 (97.7%) 6/6 (100%) 486/733 (66.3%) 0/16
(0%)
54/75 (72%)
MM–melanoma, BCC–basal cell carcinoma, SCC–squamous cell carcinoma, SK–seborrheic keratosis, SL–solar lentigo, LPLK–lichen planus like keratosis,
AK–actinic keratosis, R–reader, N/A–not applicable.
https://doi.org/10.1371/journal.pone.0187748.t002
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After randomization each reader received an average of 35 malignancies in their case series
(ranging from 25 to 42 malignancies) including an average of 16.4 MMs (ranging between 14
to 22 MMs per reader). The overall average sensitivity for single reader evaluation was 95.2%
(ranging between 86 to 100%) and specificity was 76.3% (ranging between 67 to 84%). Excision
was recommended with high confidence in 142/166 (85.5%) evaluations of 83 MMs, 83/87
(95.4%) BCCs, 4/6 (66.7%) SCCs and 81/749 (10.8%) of benign lesions. Seventeen misdiagno-
ses of a malignancy were given out of 352 evaluations of malignant lesions, including 9 times
for MM diagnosis (one of which was recommended twice for no-excision), 6 times for BCC
diagnosis (two of which were recommended twice for no-excision) and twice for SCC diagno-
sis. In the group of hypothetically mismanaged malignancies readers reported high confidence
in 2 out of 6 misdiagnosed invasive MMs, 2 out of 3 misdiagnosed in-situ MMs, 3 out of 6 mis-
diagnosed BCCs and 1 out of 2 misdiagnosed SCCs.
Considering double reading the overall sensitivity was 98.3% and specificity was 65.5% for
a cut-off threshold for excision when at least 1 reader suggested excision, regardless of their
confidence level (Table 3). Only 1/83 (1.2%) MMs, corresponding to an in-situ MM, was mis-
managed with concordant management decisions for no-excision by both readers. For BCCs
2/87 (2.3%) were mismanaged with concordant decisions of no-excision by both readers. For
SCC excision was recommended in all cases. When two readers concordantly chose to manage
a case with no-excision with both readers reporting high confidence no malignant lesions were
mismanaged (35.4%, corresponding to 292 of 824 benign lesions). In all 3 mismanaged malig-
nancies (1 in-situ MM and 2 BCCs) at least one reader reported a decision with low confi-
dence. A discordant report (one reader suggesting excision and the other no-excision) was
given for 12 malignancies (8 MMs, 2 BCCs and 2 SCCs) and 176 out of 824 benign lesions.
Concordant agreement to excise resulted in correct management of 161/176 (91.4%) of malig-
nancies and an over diagnosis of 108/824 (13.1%) benign lesions. ROC area under the curve
for double reading diagnostic performance was 0.948 (p< 0.001) (Fig 1).
Individual RCM features were evaluated (based on 2000 evaluations) for their frequencies
in the following categories: presence of pagetoid cells, architectural disarray with melanocytic
features, BCC tumor islands and/or cords and marked dyskeratosis of the epidermis (Table 4).
Table 3. Overall management performance of double reader evaluation.
Double
NEGATIVE
(2 x HC)
(-3)
Double
NEGATIVE
(1 x HC)
(-2)
Double
NEGATIVE
(0 x HC)
(-1)
1
POS
& 1
NEG
(0)
Double
POSITIVE
(0 x HC)
(+1)
Double
POSITIVE
(1 x HC)
(+2)
Double
POSITIVE
(2 x HC)
(+3)
Total
MM 0 1 0 8 3 15 56 83
BCC 0 1 1 2 0 10 73 87
SCC 0 0 0 2 0 1 3 6
Naevi
(no
spitz)
255 178 53 161 23 40 23 733
Spitz
naevi
0 0 0 2 3 2 9 16
SK/SL/
LPLK/
AK
28 11 2 11 1 3 2 58
OTHER 9 2 2 2 0 1 1 17
MM–melanoma, BCC–basal cell carcinoma, SCC–squamous cell carcinoma, SK–seborrheic keratosis, SL–
solar lentigo, LPLK–lichen planus like keratosis, AK–actinic keratosis, HC–high confidence.
https://doi.org/10.1371/journal.pone.0187748.t003
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Pagetoid cells (atypical melanocytes at the level of the epidermis) were reported in 84.3% of
MMs, 0.6% of BCCs and none of the SCCs. Pagetoid cells were also reported in benign lesions:
20.3% of naevi (excluding spitz naevi), 81.2% of spitz naevi, 8.8% of SL/SK/LPLK/AK and
2.7% of other benign lesions (p< 0.001). Architectural disarray with melanocytic features at
the level of the dermal-epidermal junction was reported in 80.1% of MMs and was completely
absent in both BCC and SCC. Frequencies of architectural disarray in benign lesions were the
Fig 1. ROC curve for double reading.
https://doi.org/10.1371/journal.pone.0187748.g001
Table 4. Reported frequencies of specific RCM features (based on 2000 evaluations).
MM BCC SCC Naevi (no
spitz)
Spitz
naevi
SK/SK/
LPLK/
AK
Other
benign
Pagetoid cells 140/
166
(84.3%)
1/174
(0.6%)
0/12
(0.0%)
297/1466
(20.3%)
26/32
(81.2%)
10/114
(8.8%)
1/36
(2.7%)
Architectural
Disarray with
melanocytic features
133/
166
(80.1%)
0/174
(0%)
0/12
(0%)
243/1466
(16.6%)
14/32
(43.8%)
6/114
(5.3%)
0/36
(0%)
BCC tumor islands/
cords
4/166
(2.4%)
155/
174
(89.1%)
2/12
(16.7%)
7/1466
(0.48%)
1/32
(3.1%)
2/114
(1.8%)
1/36
(2.7%)
Marked dyskeratosis
(epidermis)
13/166
(7.8%)
17/174
(9.8%)
7/12
(58.3%)
8/1466
(0.57%)
1/32
(3.1%)
11/114
(9.6%)
1/36
(2.7%)
MM–melanoma, BCC–basal cell carcinoma, SCC–squamous cell carcinoma, SK–seborrheic keratosis, SL–
solar lentigo, LPLK–lichen planus like keratosis, AK–actinic keratosis.
https://doi.org/10.1371/journal.pone.0187748.t004
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following: 16.6% of naevi (excluding spitz naevi), 43.8% of spitz naevi, 5.3% SL/SK/LPLK/AK
and absent in other benign lesions (p< 0.001). For the evaluation of BCC tumor islands and/
or cords their presence was reported in 89.1% of BCCs, 2.4% of MMs and 16.7% of SCCs. In
all other benign lesions BCC tumor islands and/or cords were reported in less than 1% of cases
(p< 0.001). Finally, marked dyskeratosis (greater than one third) of the epidermis was evalu-
ated with the highest frequency in SCCs 58.3% and less than 10% in all other malignant and
benign lesions (p< 0.001).
Discussion
The purpose of our study was to compare single reading versus double reading concordance
evaluation of dermoscopy-RCM image sets. In the analysis we compared evaluations made by
10 readers to either histopathology diagnosis (excised cases) or what we considered benign
lesions, those that were stable after one-year sequential digital dermoscopy in both dermo-
scopy and RCM imaging. We tested the diagnostic sensitivity and safety of evaluations in a ret-
rospective and telemedicine setting, resulting in acceptable general diagnostic accuracy for
both methods.
Unlike previous studies that tested the diagnostic accuracy of RCM based on single reader
evaluations in non-telemedicine settings where one evaluation made on-site resulted in one
simultaneous final management decision, we tested the possibility to implement RCM towards
equivocal lesions that in real-world settings may be sent for a second opinion. By adding a sec-
ond RCM reader and testing whether reader concordance and/or confidence has an impact on
potential improvement of sensitivity we aimed to reduce the limitations of single RCM reader
evaluation in both dermoscopic equivocal and confocal equivocal cases.
Previous RCM studies tested performance of single evaluators and reported variable sensi-
tivities and specificities, mainly related to different study settings, study populations and evalu-
ator expertise, but all studies demonstrated a good diagnostic performance in settings of
difficult to diagnose lesions [5–22]. Previous studies include two main types: non-interven-
tional and interventional studies. Non-interventional studies tested diagnostic accuracy in
multiple study populations that in total included 3524 lesions, including 879 MMs. These stud-
ies mostly evaluated diagnostic performance of RCM alone and differential diagnosis was pre-
dominantly based on dermoscopically equivocal lesions [5,7–10,13–22]. Reported diagnostic
sensitivity was high in all cases (ranging between 84 to 100%) and specificity variable, lower in
more difficult study populations such as those containing pink lesions [5,7] and equivocal
lesions that presented with architectural changes during sequential digital dermoscopic fol-
low-up [8,9], demonstrating the usefulness and reliability of this methodology for achieving a
precise MM diagnosis. The always superior specificity and comparable sensitivity, when com-
pared with dermoscopy alone, suggests the benefit of combined use of these technologies in
clinical settings [18,20].
The second study type, prospective interventional, is characterized by the measurement of
accuracy in real world settings with clinicians making decisions and bearing legally responsi-
bility while using RCM [6,11,12]. In these studies diagnostic and management decision was
taken using all available information including clinical and dermoscopic, explaining the excel-
lent sensitivities and on average a lower specificity. The main outcome measure was reported
as the NNE, corresponding to the number of benign lesions excised to detect one MM. Pella-
cani et al. reported a NNE of 6.8, in contrast to 14.6 without RCM, when RCM was used for
management recommendation in a more conservative setting of moderately equivocal lesions
[11]. On the other hand, Alarcon et al. stressed the use of RCM in a cohort of dermoscopically
positive lesions, reaching a reduction of the NNE from 2.87 to 1.12 [12]. Of note, the recent
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study by Borsari et al. studied a large sample size of 1279 lesions that underwent RCM exami-
nation in a real-world setting because of dermoscopy indication, similar to Alarcon et al., con-
firming the achievement of an excellent NNE and reported sensitivity of 95.3% [6]. From
literature data we can conclude that RCM use in clinical settings is both powerful and cost-
effective with the ability to save unnecessary excisions and a very low risk to mismanage a
MM, especially evident when applied to dermoscopically positive lesions [27].
However, one limitation for RCM introduction into clinical practice is due to the demon-
strated need of dedicated expert training before performing at a clinically comfortable and safe
level. Rao et al. reported a good overall diagnostic performance of RCM in a telemedicine setting,
but perfect management of all MMs was proposed only by the expert reader whereas the less
experienced reader mismanaged 1 out of 9 MMs [14]. A subsequent case revision from the same
group showed improvement of diagnostic performance in the same clinical setting after several
additional years of RCM practice in a clinical setting [28]. Similarly, Farnetani et al. showed vari-
able accuracy, ranging from a sensitivity of 88.9% and specificity of 79.3%, correlated directly
with the expertise of each evaluator [10], confirming the common assertion that RCM is accurate
and safe only in expert hands. The need for rapid transfer of essential RCM knowledge and
expertise in order to immediately offer the clinical benefits of RCM into practice is supportive of
telemedicine application in this field of non-invasive skin cancer screening [29]. However, a tele-
medicine setting is only able to transfer part of the information and does not permit the "in per-
son patient-doctor experience" which may sometimes be relevant to perceive diagnostic hints
and clinical clues able to instinctively direct the clinician to the correct management.
In this study we aimed to test the validity of a RCM telemedicine setting to support diagno-
sis at a distance and to identify potential strategies that may minimize the risk of MM misman-
agement in clinical settings. In our study there were no expert confocal readers involved, but
each of the 10 readers received identical dedicated training during a 6 month period for the
purpose of future telemedicine evaluation. All 10 readers in our study followed a specific train-
ing program that included the individual study and courses entailing dermoscopy and RCM
textbooks for skin cancer diagnosis as well as a minimum of 3 months daily exposure to our
dermoscopy and RCM outpatient clinic with at least 2000 clinical cases observed and discussed
with a tutor.
The dermoscopy-RCM image sets in our study assessed by single reader evaluation repro-
duced the context of a telemedicine setting and resulted in an overall sensitivity of 95.2% (range:
86 to 100%) and specificity of 76.3% (minimum: 67.5%). Our data is consistent with published
literature showing that RCM has a high sensitivity for malignancies: 94.0% for MM, 96.5% for
BCC and 87.5% for SCC as well as high specificity for naevi (excluding spitz naevi) (77.5%) and
the group of SK/SL/LPLK/AK (79.6%). Overall single reader evaluation resulted in the misman-
agement of 8 individual MMs, 4 BCCs and 2 SCCs (based on 2000 total evaluations). These ini-
tial results illustrate the potential limitation of single reader evaluation where the diagnostic
sensitivity may not be high enough for safe management of MM and allow for potentially dan-
gerous misdiagnosis of lesions that are already invasive or can be life threatening in their pro-
gression. This limitation can be attributed to a variety of factors including: lack of sufficient
training, limited clinical exposure to RCM, confidence variability, different evaluation criteria
followed, fatigue or expediting completion of a high volume of cases in different scenarios.
The addition of a second reader with management for excision made when excision was
recommended in at least one of the two evaluations improved the overall sensitivity to 98.3%
and lowered specificity to 65.5% (10.8% reduction) resulting in hypothetical mismanagement
of only 1 in-situ MM and 2 BCCs. The effect of double reader performance decreased the likeli-
hood of mismanagement of an invasive MM in the study population while maintaining an
acceptable specificity where the number of unnecessary excision of benign lesions was
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comparable to that of single reading and to current data from real-world settings [6,11,12].
The mismanaged in-situ MM was a diagnostic challenge upon initial presentation. Upon histo-
pathology examination this lesion was characterized by a predominantly lentiginous atypical
melanocytic proliferation, consistent with the pattern of lentiginous MM, that represents a
slowly progressing variant of MM [30,31]. This lesion was placed into sequential digital der-
moscopy follow-up during the first patient visit and was detected during second visit control
examination and subsequently removed at that time. The two BCCs cases mismanaged were
both small superficial types present on the trunk. Since BCC rarely metastasis these misman-
aged false negative lesions would not present significant health risk to these patients and most
likely would be diagnosed on a future follow-up digital dermoscopy visit when dermoscopic
features would become mature and more apparent.
For individual RCM features we evaluated the frequency of the presence of pagetoid cells,
architectural disarray with melanocytic features, BCC tumor islands and/or cords and marked
dyskeratosis of the epidermis. Pagetoid cells were reported in 84.3% of MM, 81.2% of spitz
naevi and 20.3% of naevi (excluding spitz naevi) as well as architectural disarray with presence
of melanocytic features at the DEJ in in 80.1% of MM, 43.8% of spitz naevi and 16.6% of naevi
(excluding spitz naevi). These frequencies demonstrate that both pagetoid cells and architec-
tural disarray with melanocytic features at the DEJ are prevalent features of MM. Since both of
these features overlap into the category spitz naevi our data is in line with recent publications
showing the limitation of RCM in distinguishing spitz naevi from MM, in our study overall
single reader specificity was 6.2% and double reader specificity was 0% [32,33]. In the naevi
category (excluding spitz naevi) both of these features were present in low but notable frequen-
cies demonstrating their presence in selected groups of melanocytic naevi, particularly those
that are congenital, traumatized and/or dysplastic [34,35]. Additionally, the frequencies of
BCC tumor islands and/or cords in the BCC population (89.1%) and dyskeratosis in the SCC
population (58.3%) were also consistent with literature highlighting their presence as specific
for BCC and common in SCC [36–38].
Compared to previously reported methods and technology utilized for skin cancer diag-
nosis, RCM resulted in a superior combined sensitivity and specificity when applied to der-
moscopically equivocal lesions. As examples, multispectral imaging studies reported high
sensitivity but have always been associated with poor specificity [39,40]. Monheit et al. per-
formed a prospective, multicenter, blinded study of 1632 lesions and used multispectral
imaging to differentiate cutaneous MMs from melanocytic skin lesions using histology as
the reference standard. Standard images and patient information for a subset of 50 ran-
domly selected lesions (25 MMs) were used in a reader study of 39 independent dermatolo-
gists, resulting in an overall sensitivity of 98.3% and specificity of 9.9% [39]. Lui et al.
evaluated 1022 lesions testing Raman-spectroscopy in-vivo and reported that for high sensi-
tivities (95% to 99%) the specificities ranged between 15% and 54% [41], data confirmed in
other studies [42,43]. The OCT method is very popular with BCC diagnosis [44,45], but has
limited application in differentiating melanocytic tumors due to its lower resolution than
RCM [46]. Although Gambichler et al. reported a sensitivity of 74.1% and specificity of
92.4% in the differentiation of cutaneous MM and melanocytic naevi, the authors only
included clear MMs and benign lesions, not equivocal ones, which may have given OCT an
artificially positive outlook in its application to pigmented lesions [47]. Due to the high res-
olution and the capability to detect cell metabolic activity, in-vivo multiphoton microscopy
is a promising research tool in the field of MM diagnosis [48]. Dimitrow et al. tested in-vivo
multiphoton microscopy application in 53 melanocytic lesions (of which there were 26
MMs, 8 of which were in-situ) and reported sensitivity up to 95% and specificity up to 97%
in the detection of MM [49]. This technology seems to be very accurate but is limited in
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clinical settings due to its single point view of a skin lesion prohibiting full-field of view and
in time-restrained settings where complete visualization of a cutaneous lesion architecture
is necessary to make an accurate diagnosis, mismanagement of MM is possible [50].
In our study it is important to consider the limitation of reader performance based on a ret-
rospective study setting where readers may obtain a higher performance when liability is
absent. In consideration of this variable, results in real-world clinical and telemedicine settings
may be lower than our own. Therefore, the application of double reading concordance may
supplement this potential reduction of performance. Additionally, several malignant cases
were managed as benign with high confidence by single reader evaluation when they were in
fact malignant and invasive. When the same lesion management was paired in a double read-
ing concordance setting this potentially dangerous mismanagement was reduced due to deci-
sion to excise lesions when the double reading was discordant or management decision was
concordant for excision.
Double reading enhanced the diagnostic sensitivity and reduced the likelihood to misman-
age an invasive MM with the limitation shown to be in in-situ lesions, impossible to detect on
initial presentation with traditional naked-eye examination as well as a low chance of detection
using dermoscopy. These in-situ lesions can be well managed with annual screenings and regis-
tration of suspicious lesions with sequential digital dermoscopy monitoring. The optimal
threshold of safety and accuracy in our study was when two readers managed a skin lesion with
concordant benign diagnosis resulting (no-excision) and management of excision when at least
one reader was proposing management with excision (discordance). The expected sensitivity/
specificity tradeoff must always be considered with any type of screening test and in our study
the use of double reading brought sensitivity closer to 100% while reducing specificity from its
single reader baseline by only 10.8%. Since an additional benefit of RCM implementation is the
reduction of unnecessary excisions, calculated by NNE, this variable should be considered [3].
In conclusion, integration of dermoscopy-RCM imaging is valid in a clinical setting and may
be reliable for second expert consultation via telemedicine by adding confidence to equivocal
dermoscopic evaluation. The double reader concordance approach may minimize the risk to
mismanage a potentially life-threatening skin cancer while maintaining acceptable specificity.
Patient screening and sequential digital dermoscopy follow-up should be recommended for all
equivocal lesions that are not excised on first visits in order to detect changes over time that
may not be visible at initial presentation and initiation of sequential digital dermoscopy (mole-
mapping) programs should be considered. Given the high variability of sensitivity and specific-
ity amongst the readers it is important to consider implementation of standardized training and
reading programs to help minimize the risk of potential mismanagement using RCM in both
clinical and store-and-forward telemedicine settings. Furthermore, a prospective study seems
necessary in order to evaluate this promising technology in a real-time telemedicine scenario.
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